COVID-19 / Multiple Myeloma Update with Joshua Richter, MD, Mount SinaiNOVEMBER 25, 2020A fascinating update from Joshua Richter, MD of Mount Sinai on what multiple myeloma patients need to consider now that we know more about COVID-19.

COVID-19 / Multiple Myeloma Update with Joshua Richter, MD, Mount SinaiNOVEMBER 25, 2020A fascinating update from Joshua Richter, MD of Mount Sinai on what multiple myeloma patients need to consider now that we know more about COVID-19.
Event Description
Joshua Richter, MD
Mount Sinai
Interview Date: November 6, 2020
COVID-19 is still a serious condition for multiple myeloma patients. With a 28% death rate for hospitalized myeloma patients, it is important that patients understand the latest. What have we learned? Dr. Joshua Richter of Mount Sinai shares important information about the status of myeloma care in relation to COVID-19, how patients can best protect themselves, if you should be getting IVIG, possible treatments for COVID, why you should go back to normal myeloma therapy whether you should take blood thinners and much more.
Thanks to our episode sponsor
Schedule & Agenda
Speakers & Moderators
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org






Get the Latest Multiple Myeloma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.